{"id": "article-29792_0", "title": "Sydenham Chorea -- Continuing Education Activity", "content": "Sydenham chorea, or St. Vitus dance, is caused by group A \u03b2-hemolytic streptococcal infections and is a manifestation of rheumatic fever that occurs in up to 40 percent of patients with rheumatic fever. Anti-basal ganglia antibodies develop and attack portions of the brain, leading to pathologic findings and symptoms.\u00a0Sydenham chorea is much less common today than it was in the past. When it does occur, however, the symptoms are typically less severe, and the relapses are less frequent. This activity reviews Sydenham chorea's causes and presentation and highlights the interprofessional team's role in its management.", "contents": "Sydenham Chorea -- Continuing Education Activity. Sydenham chorea, or St. Vitus dance, is caused by group A \u03b2-hemolytic streptococcal infections and is a manifestation of rheumatic fever that occurs in up to 40 percent of patients with rheumatic fever. Anti-basal ganglia antibodies develop and attack portions of the brain, leading to pathologic findings and symptoms.\u00a0Sydenham chorea is much less common today than it was in the past. When it does occur, however, the symptoms are typically less severe, and the relapses are less frequent. This activity reviews Sydenham chorea's causes and presentation and highlights the interprofessional team's role in its management."}
{"id": "article-29792_1", "title": "Sydenham Chorea -- Continuing Education Activity", "content": "Objectives: Identify early manifestations of Sydenham chorea to facilitate prompt diagnosis. Differentiate Sydenham chorea from other movement disorders through comprehensive clinical evaluation. Select suitable medications, including corticosteroids or other immunomodulatory agents, tailored to the patient. Collaborate with the interprofessional team to\u00a0enhance care coordination and improve patient outcomes. Access free multiple choice questions on this topic.", "contents": "Sydenham Chorea -- Continuing Education Activity. Objectives: Identify early manifestations of Sydenham chorea to facilitate prompt diagnosis. Differentiate Sydenham chorea from other movement disorders through comprehensive clinical evaluation. Select suitable medications, including corticosteroids or other immunomodulatory agents, tailored to the patient. Collaborate with the interprofessional team to\u00a0enhance care coordination and improve patient outcomes. Access free multiple choice questions on this topic."}
{"id": "article-29792_2", "title": "Sydenham Chorea -- Introduction", "content": "Sydenham chorea,\u00a0or St. Vitus dance, is a major manifestation of rheumatic fever in up to\u00a040% of patients with rheumatic fever. It is uncommon in the United States but occurs much more frequently in developing countries. This neuropsychiatric disorder is thought to be mediated by an\u00a0autoimmune process resulting from antigenic mimicry between\u00a0central nervous system basal ganglia cells\u00a0and group A \u03b2-hemolytic Streptococci antigens. [1] [2] Anti-basal ganglia antibodies\u00a0that\u00a0result from the antigenic mimicry attack portions of the brain, especially the dorsal and ventral striatum, and are responsible for the pathological\u00a0findings and symptoms.", "contents": "Sydenham Chorea -- Introduction. Sydenham chorea,\u00a0or St. Vitus dance, is a major manifestation of rheumatic fever in up to\u00a040% of patients with rheumatic fever. It is uncommon in the United States but occurs much more frequently in developing countries. This neuropsychiatric disorder is thought to be mediated by an\u00a0autoimmune process resulting from antigenic mimicry between\u00a0central nervous system basal ganglia cells\u00a0and group A \u03b2-hemolytic Streptococci antigens. [1] [2] Anti-basal ganglia antibodies\u00a0that\u00a0result from the antigenic mimicry attack portions of the brain, especially the dorsal and ventral striatum, and are responsible for the pathological\u00a0findings and symptoms."}
{"id": "article-29792_3", "title": "Sydenham Chorea -- Introduction", "content": "Sydenham chorea is much less common today than in the past, but when it does occur, the symptoms are less severe, and the relapses are less frequent.\u00a0This may be partially due to aggressive treatment of group A streptococcal infections, improved general hygiene practices, and a reduction in the strain of group A Streptococcus that\u00a0causes the antigenic\u00a0mimicry that triggers the disease. The Jones Criteria\u00a0proposed by TD Jones\u00a0for the diagnosis of rheumatic fever included Sydenham chorea as a major criterion when diagnosing rheumatic fever. [3] [4] A very high proportion of rheumatic fever patients who develop Sydenham chorea suffer from carditis and develop valvular heart disease.", "contents": "Sydenham Chorea -- Introduction. Sydenham chorea is much less common today than in the past, but when it does occur, the symptoms are less severe, and the relapses are less frequent.\u00a0This may be partially due to aggressive treatment of group A streptococcal infections, improved general hygiene practices, and a reduction in the strain of group A Streptococcus that\u00a0causes the antigenic\u00a0mimicry that triggers the disease. The Jones Criteria\u00a0proposed by TD Jones\u00a0for the diagnosis of rheumatic fever included Sydenham chorea as a major criterion when diagnosing rheumatic fever. [3] [4] A very high proportion of rheumatic fever patients who develop Sydenham chorea suffer from carditis and develop valvular heart disease."}
{"id": "article-29792_4", "title": "Sydenham Chorea -- Etiology", "content": "Sydenham chorea\u00a0is believed to be an autoimmune disorder typically occurring after a group A \u03b2-Hemolytic streptococcal infection. The immune system is stimulated to produce antibodies against streptococcal bacterial infection. These antibodies cross-react\u00a0with basal ganglia cells, especially striatum cells, which are important in controlling motor movements. Death and damage to these cells are considered responsible for the disease's manifestations.", "contents": "Sydenham Chorea -- Etiology. Sydenham chorea\u00a0is believed to be an autoimmune disorder typically occurring after a group A \u03b2-Hemolytic streptococcal infection. The immune system is stimulated to produce antibodies against streptococcal bacterial infection. These antibodies cross-react\u00a0with basal ganglia cells, especially striatum cells, which are important in controlling motor movements. Death and damage to these cells are considered responsible for the disease's manifestations."}
{"id": "article-29792_5", "title": "Sydenham Chorea -- Epidemiology", "content": "The disease\u00a0typically\u00a0is delayed 6 to 8 weeks after group A \u03b2-hemolytic streptococcal pharyngitis; it does not occur after skin infections. Sydenham chorea is more prevalent in females than males (3:1). Sydenham chorea is primarily a childhood disease, with most affected patients\u00a0aged 5\u00a0to 18.\u00a0The disease is rarely\u00a0reported in children\u00a0younger\u00a0than 5; the\u00a0peak age is 8 to 9. Sydenham chorea affects children of all ethnicities and races.\u00a0Sydenham chorea\u00a0is a major Jones criterion for rheumatic fever. Around 25% of patients with rheumatic fever develop Sydenham chorea, the incidence of which has declined steadily over the past few decades in North America due to the steady decline in the incidence of rheumatic fever and the more widespread use of antibiotics. [5]", "contents": "Sydenham Chorea -- Epidemiology. The disease\u00a0typically\u00a0is delayed 6 to 8 weeks after group A \u03b2-hemolytic streptococcal pharyngitis; it does not occur after skin infections. Sydenham chorea is more prevalent in females than males (3:1). Sydenham chorea is primarily a childhood disease, with most affected patients\u00a0aged 5\u00a0to 18.\u00a0The disease is rarely\u00a0reported in children\u00a0younger\u00a0than 5; the\u00a0peak age is 8 to 9. Sydenham chorea affects children of all ethnicities and races.\u00a0Sydenham chorea\u00a0is a major Jones criterion for rheumatic fever. Around 25% of patients with rheumatic fever develop Sydenham chorea, the incidence of which has declined steadily over the past few decades in North America due to the steady decline in the incidence of rheumatic fever and the more widespread use of antibiotics. [5]"}
{"id": "article-29792_6", "title": "Sydenham Chorea -- Epidemiology", "content": "Adult onset of Sydenham chorea is uncommon, and most adult cases are usually secondary to\u00a0recurrence following childhood illness. The incidence is higher in\u00a0developing countries due to \u03b2-hemolytic S treptococci infection and inadequate treatment of streptococci infection, exacerbated by overcrowding and poor hygienic conditions. Chorea gravidarum is a pregnancy-related variant. Most cases are a\u00a0recurrence of SC and are considered to be due to the hormonal\u00a0changes of pregnancy, but it also\u00a0can be precipitated by the use of oral contraceptives. Symptoms often resolve quickly immediately after delivery.", "contents": "Sydenham Chorea -- Epidemiology. Adult onset of Sydenham chorea is uncommon, and most adult cases are usually secondary to\u00a0recurrence following childhood illness. The incidence is higher in\u00a0developing countries due to \u03b2-hemolytic S treptococci infection and inadequate treatment of streptococci infection, exacerbated by overcrowding and poor hygienic conditions. Chorea gravidarum is a pregnancy-related variant. Most cases are a\u00a0recurrence of SC and are considered to be due to the hormonal\u00a0changes of pregnancy, but it also\u00a0can be precipitated by the use of oral contraceptives. Symptoms often resolve quickly immediately after delivery."}
{"id": "article-29792_7", "title": "Sydenham Chorea -- Pathophysiology", "content": "Most authorities believe Sydenham chorea to be an autoimmune disease that is\u00a0triggered by a group A \u03b2-hemolytic streptococcal infection, subsequently resulting in a hypersensitivity humoral reaction to the infection and cross-reactivity of streptococcal antigens and human tissue antigens through molecular mimicry. [6] The\u00a0stimulated antibodies target the\u00a0basal ganglia brain\u00a0cells in the host and\u00a0cause a diffuse inflammatory process in the dorsal corpus striatum, mainly the caudate nucleus and putamen. The ventral striatum, especially the nucleus accumbens, is also affected, resulting in Sydenham chorea's frequently associated cognitive and behavioral symptoms.\u00a0The symptoms of Sydenham chorea are caused by an imbalance between the dopaminergic system, intrastriatal cholinergic system, and the inhibitory gamma-aminobutyric acid (GABA) system. Sydenham chorea is often considered the model for pediatric autoimmune neuropsychiatric disorders. [7]", "contents": "Sydenham Chorea -- Pathophysiology. Most authorities believe Sydenham chorea to be an autoimmune disease that is\u00a0triggered by a group A \u03b2-hemolytic streptococcal infection, subsequently resulting in a hypersensitivity humoral reaction to the infection and cross-reactivity of streptococcal antigens and human tissue antigens through molecular mimicry. [6] The\u00a0stimulated antibodies target the\u00a0basal ganglia brain\u00a0cells in the host and\u00a0cause a diffuse inflammatory process in the dorsal corpus striatum, mainly the caudate nucleus and putamen. The ventral striatum, especially the nucleus accumbens, is also affected, resulting in Sydenham chorea's frequently associated cognitive and behavioral symptoms.\u00a0The symptoms of Sydenham chorea are caused by an imbalance between the dopaminergic system, intrastriatal cholinergic system, and the inhibitory gamma-aminobutyric acid (GABA) system. Sydenham chorea is often considered the model for pediatric autoimmune neuropsychiatric disorders. [7]"}
{"id": "article-29792_8", "title": "Sydenham Chorea -- Histopathology", "content": "Sydenham chorea is caused by a\u00a0hypersensitivity\u00a0humoral\u00a0response triggered by an infection with group A \u03b2-hemolytic S treptococcus. The subsequent immune inflammatory response attacks and destroys cells of the basal ganglia.", "contents": "Sydenham Chorea -- Histopathology. Sydenham chorea is caused by a\u00a0hypersensitivity\u00a0humoral\u00a0response triggered by an infection with group A \u03b2-hemolytic S treptococcus. The subsequent immune inflammatory response attacks and destroys cells of the basal ganglia."}
{"id": "article-29792_9", "title": "Sydenham Chorea -- History and Physical", "content": "Sydenham chorea often presents following other symptoms and signs of rheumatic fever, but it can occur alone. Isolated attacks, without other rheumatic fever symptoms, are common in\u00a0recurrent chorea attacks. Typically, the first episode occurs 6 to 8 weeks after an episode of group A \u03b2-hemolytic S treptococcus ( GABHS) pharyngitis. The features of the chorea include involuntary movements, poor tone and muscular weakness, and psychological features. The involuntary movements are the cardinal signs of Sydenham chorea and are\u00a0characterized by the abrupt onset of symptoms that usually affect all 4 limbs. Other motor symptoms include gait disturbances, loss of motor control, deterioration of handwriting, and development of cognitive or emotional disorders. Facial grimacing\u00a0or tongue chorea may develop. The patients may demonstrate\u00a0the \"milkmaid sign,\" a relapsing grip\u00a0similar to the handgrip while milking a cow. Tics are common in Sydenham chorea. Vocal tics occur in 70% of patients and\u00a0are believed\u00a0to be related to the chorea of the pharynx and larynx. Dysarthria is common, as well as decreased verbal fluency due to the involvement of bulbar muscles. Overall, around 70% of patients have generalized chorea, 30 to 35% have hemichorea, and 60% have other neurological symptoms, including dysarthria and dysgraphia. [8]", "contents": "Sydenham Chorea -- History and Physical. Sydenham chorea often presents following other symptoms and signs of rheumatic fever, but it can occur alone. Isolated attacks, without other rheumatic fever symptoms, are common in\u00a0recurrent chorea attacks. Typically, the first episode occurs 6 to 8 weeks after an episode of group A \u03b2-hemolytic S treptococcus ( GABHS) pharyngitis. The features of the chorea include involuntary movements, poor tone and muscular weakness, and psychological features. The involuntary movements are the cardinal signs of Sydenham chorea and are\u00a0characterized by the abrupt onset of symptoms that usually affect all 4 limbs. Other motor symptoms include gait disturbances, loss of motor control, deterioration of handwriting, and development of cognitive or emotional disorders. Facial grimacing\u00a0or tongue chorea may develop. The patients may demonstrate\u00a0the \"milkmaid sign,\" a relapsing grip\u00a0similar to the handgrip while milking a cow. Tics are common in Sydenham chorea. Vocal tics occur in 70% of patients and\u00a0are believed\u00a0to be related to the chorea of the pharynx and larynx. Dysarthria is common, as well as decreased verbal fluency due to the involvement of bulbar muscles. Overall, around 70% of patients have generalized chorea, 30 to 35% have hemichorea, and 60% have other neurological symptoms, including dysarthria and dysgraphia. [8]"}
{"id": "article-29792_10", "title": "Sydenham Chorea -- History and Physical", "content": "Behavioral problems are common. The most common was anxiety disorder/depression (77%). [8] Obsessions and compulsions are present in up to 70% of patients, and 16.7% meet the criteria for obsessive-compulsive disorder. Hyperactivity and attention deficit disorder has been found in up to 45% of patients. Psychosis has been reported in the acute phase of the illness. Carditis occurs in up to 80% of patients. [9] Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)\u00a0is a controversial diagnosis in which patients develop a\u00a0rather acute onset of OCD and tics that persist despite treatment. [10]", "contents": "Sydenham Chorea -- History and Physical. Behavioral problems are common. The most common was anxiety disorder/depression (77%). [8] Obsessions and compulsions are present in up to 70% of patients, and 16.7% meet the criteria for obsessive-compulsive disorder. Hyperactivity and attention deficit disorder has been found in up to 45% of patients. Psychosis has been reported in the acute phase of the illness. Carditis occurs in up to 80% of patients. [9] Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)\u00a0is a controversial diagnosis in which patients develop a\u00a0rather acute onset of OCD and tics that persist despite treatment. [10]"}
{"id": "article-29792_11", "title": "Sydenham Chorea -- History and Physical", "content": "Chorea gravidarum is a syndrome describing the onset of chorea during pregnancy. It is not a specific disease. Rheumatic fever, or a history of rheumatic fever, was the most typical cause, indicating that it is the same as Sydenham's chorea. These patients also have similar pathological changes in the brain. [11] Due to the decline in the incidence of rheumatic fever, it is not a significant cause of chorea gravidarum nowadays. The primary pathophysiological mechanism remains immune-mediated, frequently linked to underlying autoimmune conditions like antiphospholipid antibody syndromes. [12] The other etiological hypothesis is hormonal changes, especially estrogen, during pregnancy and the use of oral contraceptives.", "contents": "Sydenham Chorea -- History and Physical. Chorea gravidarum is a syndrome describing the onset of chorea during pregnancy. It is not a specific disease. Rheumatic fever, or a history of rheumatic fever, was the most typical cause, indicating that it is the same as Sydenham's chorea. These patients also have similar pathological changes in the brain. [11] Due to the decline in the incidence of rheumatic fever, it is not a significant cause of chorea gravidarum nowadays. The primary pathophysiological mechanism remains immune-mediated, frequently linked to underlying autoimmune conditions like antiphospholipid antibody syndromes. [12] The other etiological hypothesis is hormonal changes, especially estrogen, during pregnancy and the use of oral contraceptives."}
{"id": "article-29792_12", "title": "Sydenham Chorea -- Evaluation", "content": "There are no specific ancillary tests to provide a definitive diagnosis of the illness. All patients with chorea need a detailed neurologic and cardiac evaluation. Routine blood tests should include a complete blood count (CBC), complete\u00a0metabolic\u00a0panel (CMP), liver function test (LFT), B12 (deficiency in children can lead to chorea), thyroid-stimulating hormone (TSH), and drug screens. Antistreptolysin-O titer (ASOT) and anti-DNAse B titers are important tests to request. Anti-DNAse B titers may be elevated up to one year after group A streptococcal pharyngitis. Due to the latency between the initial pharyngeal infection and the onset of the chorea, acute phase reactants such as C-reactive protein and erythrocyte sedimentation rates have limited utility. Echocardiograms are indicated to evaluate for carditis, as up to 80% of patients with Sydenham chorea have a\u00a0concurrent cardiac disease. [13] [14]", "contents": "Sydenham Chorea -- Evaluation. There are no specific ancillary tests to provide a definitive diagnosis of the illness. All patients with chorea need a detailed neurologic and cardiac evaluation. Routine blood tests should include a complete blood count (CBC), complete\u00a0metabolic\u00a0panel (CMP), liver function test (LFT), B12 (deficiency in children can lead to chorea), thyroid-stimulating hormone (TSH), and drug screens. Antistreptolysin-O titer (ASOT) and anti-DNAse B titers are important tests to request. Anti-DNAse B titers may be elevated up to one year after group A streptococcal pharyngitis. Due to the latency between the initial pharyngeal infection and the onset of the chorea, acute phase reactants such as C-reactive protein and erythrocyte sedimentation rates have limited utility. Echocardiograms are indicated to evaluate for carditis, as up to 80% of patients with Sydenham chorea have a\u00a0concurrent cardiac disease. [13] [14]"}
{"id": "article-29792_13", "title": "Sydenham Chorea -- Evaluation", "content": "Brain MRI and CT scans\u00a0typically\u00a0are normal, although occasional reversible hyperintensity may occur in the basal ganglia. In children, obtaining an MRI is of questionable use, given the requirements for sedation, and careful consideration should be made on a case-by-case basis. The new onset of chorea in adults may indicate a structural basal ganglia pathology, especially in the striatum. A brain MRI in such cases will be strongly indicated. PET scans and SPECT imaging have demonstrated hypermetabolism and hyperperfusion of the basal ganglia in case reports, whereas other chorea\u00a0disorders are associated with hypometabolism. These tests are rarely indicated except in research.", "contents": "Sydenham Chorea -- Evaluation. Brain MRI and CT scans\u00a0typically\u00a0are normal, although occasional reversible hyperintensity may occur in the basal ganglia. In children, obtaining an MRI is of questionable use, given the requirements for sedation, and careful consideration should be made on a case-by-case basis. The new onset of chorea in adults may indicate a structural basal ganglia pathology, especially in the striatum. A brain MRI in such cases will be strongly indicated. PET scans and SPECT imaging have demonstrated hypermetabolism and hyperperfusion of the basal ganglia in case reports, whereas other chorea\u00a0disorders are associated with hypometabolism. These tests are rarely indicated except in research."}
{"id": "article-29792_14", "title": "Sydenham Chorea -- Treatment / Management", "content": "In the past, the illness was considered benign\u00a0and typically would remit after a few months. More recent studies have found that up to half of the patients have chorea lasting up to 2 years. Recurrences of movement disorders occur in up to 50% of patients regardless of prophylaxis. Many of these recurrences have not been associated with Streptococcus infection or anti-basal ganglia antibodies. A significant concern for patients with the illness is the development of valvular heart disease as a component of rheumatic fever. There is a strong correlation between Sydenham chorea and the development of carditis and valvular heart disease. [15] [16]", "contents": "Sydenham Chorea -- Treatment / Management. In the past, the illness was considered benign\u00a0and typically would remit after a few months. More recent studies have found that up to half of the patients have chorea lasting up to 2 years. Recurrences of movement disorders occur in up to 50% of patients regardless of prophylaxis. Many of these recurrences have not been associated with Streptococcus infection or anti-basal ganglia antibodies. A significant concern for patients with the illness is the development of valvular heart disease as a component of rheumatic fever. There is a strong correlation between Sydenham chorea and the development of carditis and valvular heart disease. [15] [16]"}
{"id": "article-29792_15", "title": "Sydenham Chorea -- Treatment / Management", "content": "The treatment modalities of Sydenham chorea can be considered in\u00a03 parts: prophylactic penicillin therapy, symptomatic treatments with antipsychotics or anticonvulsants, and immunomodulating therapy with steroids, intravenous immunoglobulin (IVIg), and plasma exchange. [17]", "contents": "Sydenham Chorea -- Treatment / Management. The treatment modalities of Sydenham chorea can be considered in\u00a03 parts: prophylactic penicillin therapy, symptomatic treatments with antipsychotics or anticonvulsants, and immunomodulating therapy with steroids, intravenous immunoglobulin (IVIg), and plasma exchange. [17]"}
{"id": "article-29792_16", "title": "Sydenham Chorea -- Treatment / Management", "content": "Prevention of the SD by aggressively treating Group A B-hemolytic streptococcal pharyngeal infection\u00a0and reducing the likelihood of rheumatic heart disease is effective. Once Sydenham chorea is diagnosed, secondary antibiotic\u00a0prophylaxis is indicated to decrease the risk of neurologic and cardiac problems with future streptococcal infections. The World Health Organization (WHO) recommends secondary prophylaxis\u00a0for those younger than 21.", "contents": "Sydenham Chorea -- Treatment / Management. Prevention of the SD by aggressively treating Group A B-hemolytic streptococcal pharyngeal infection\u00a0and reducing the likelihood of rheumatic heart disease is effective. Once Sydenham chorea is diagnosed, secondary antibiotic\u00a0prophylaxis is indicated to decrease the risk of neurologic and cardiac problems with future streptococcal infections. The World Health Organization (WHO) recommends secondary prophylaxis\u00a0for those younger than 21."}
{"id": "article-29792_17", "title": "Sydenham Chorea -- Treatment / Management", "content": "Symptomatic treatment of the illness has not been well-studied. Typically, valproic acid has been used in escalating doses, starting at 250 mg per day and rapidly increasing to 1500 mg per day or until symptoms abate. Valproic acid\u00a0does have a slow onset of action; thus, at least\u00a02 weeks should be allowed before abandoning it as ineffective. The second-line treatment if valproic acid fails is neuroleptics. Risperidone 1 mg to 2 mg\u00a0per day\u00a0has been found effective in controlling the chorea. [18] However, they increase the risk of tardive dyskinesia.\u00a0More recently, tetrabenazine, a dopamine-depleting agent with fewer potential side effects, has been suggested.\u00a0Its effectiveness is not well studied. Immunosuppression is ineffective in the management of the illness. Immunomodulating therapy is generally reserved for more resistant and refractory Sydenham chorea. Steroids are generally beneficial. Data on IVIg and plasma exchange are more limited. [17]", "contents": "Sydenham Chorea -- Treatment / Management. Symptomatic treatment of the illness has not been well-studied. Typically, valproic acid has been used in escalating doses, starting at 250 mg per day and rapidly increasing to 1500 mg per day or until symptoms abate. Valproic acid\u00a0does have a slow onset of action; thus, at least\u00a02 weeks should be allowed before abandoning it as ineffective. The second-line treatment if valproic acid fails is neuroleptics. Risperidone 1 mg to 2 mg\u00a0per day\u00a0has been found effective in controlling the chorea. [18] However, they increase the risk of tardive dyskinesia.\u00a0More recently, tetrabenazine, a dopamine-depleting agent with fewer potential side effects, has been suggested.\u00a0Its effectiveness is not well studied. Immunosuppression is ineffective in the management of the illness. Immunomodulating therapy is generally reserved for more resistant and refractory Sydenham chorea. Steroids are generally beneficial. Data on IVIg and plasma exchange are more limited. [17]"}
{"id": "article-29792_18", "title": "Sydenham Chorea -- Differential Diagnosis", "content": "Sydenham chorea should be differentiated\u00a0from other causes of chorea, including autoimmune, toxic, vascular, and genetic causes. The acuity of onset can assist in diagnosis. The toxic and vascular causes are\u00a0more acute to subacute, and the genetic causes are more gradual. Family is typically, but not always, present in the latter. Acute onset of chorea in a child is most commonly due to Sydenham chorea as a manifestation of acute rheumatic fever and systemic lupus erythematosus (SLE) in the presence of antiphospholipid antibody. The following list of differential diagnoses also needs to be considered: Huntington disease Acute stroke affecting the basal ganglia Medications, including dopaminergic and dopamine antagonists Hypoglycemia and nonketotic hyperglycemia Lyme disease Multiple system atrophy Neuroacanthocytosis Neuronal ceroid Lipofuscinoses Olivopontocerebellar atrophy [19] [20]", "contents": "Sydenham Chorea -- Differential Diagnosis. Sydenham chorea should be differentiated\u00a0from other causes of chorea, including autoimmune, toxic, vascular, and genetic causes. The acuity of onset can assist in diagnosis. The toxic and vascular causes are\u00a0more acute to subacute, and the genetic causes are more gradual. Family is typically, but not always, present in the latter. Acute onset of chorea in a child is most commonly due to Sydenham chorea as a manifestation of acute rheumatic fever and systemic lupus erythematosus (SLE) in the presence of antiphospholipid antibody. The following list of differential diagnoses also needs to be considered: Huntington disease Acute stroke affecting the basal ganglia Medications, including dopaminergic and dopamine antagonists Hypoglycemia and nonketotic hyperglycemia Lyme disease Multiple system atrophy Neuroacanthocytosis Neuronal ceroid Lipofuscinoses Olivopontocerebellar atrophy [19] [20]"}
{"id": "article-29792_19", "title": "Sydenham Chorea -- Complications", "content": "Most make a full recovery in\u00a03 to\u00a06 months. A small number of children continue experiencing symptoms for up to\u00a02 years. Symptoms can also return later in life, especially in people AFAB who take estrogen\u00a0or birth control pills or get pregnant.", "contents": "Sydenham Chorea -- Complications. Most make a full recovery in\u00a03 to\u00a06 months. A small number of children continue experiencing symptoms for up to\u00a02 years. Symptoms can also return later in life, especially in people AFAB who take estrogen\u00a0or birth control pills or get pregnant."}
{"id": "article-29792_20", "title": "Sydenham Chorea -- Pearls and Other Issues", "content": "The most\u00a0significant causes of acute onset of chorea in children are Sydenham chorea and systemic lupus with antiphospholipid antibodies.", "contents": "Sydenham Chorea -- Pearls and Other Issues. The most\u00a0significant causes of acute onset of chorea in children are Sydenham chorea and systemic lupus with antiphospholipid antibodies."}
{"id": "article-29792_21", "title": "Sydenham Chorea -- Pearls and Other Issues", "content": "Drugs, including dopaminergic, anti-dopaminergic, and cholinergic, among others, have been identified as the cause of chorea (often referred to as dyskinesia or tardive dyskinesia). Cocaine and amphetamines have also been implicated. Stroke, demyelinating disease, hypoglycemia or hyperglycemia (diabetic striatopathy), liver disease, and anoxia should be included in the differential, although these typically present\u00a0in older age.", "contents": "Sydenham Chorea -- Pearls and Other Issues. Drugs, including dopaminergic, anti-dopaminergic, and cholinergic, among others, have been identified as the cause of chorea (often referred to as dyskinesia or tardive dyskinesia). Cocaine and amphetamines have also been implicated. Stroke, demyelinating disease, hypoglycemia or hyperglycemia (diabetic striatopathy), liver disease, and anoxia should be included in the differential, although these typically present\u00a0in older age."}
{"id": "article-29792_22", "title": "Sydenham Chorea -- Pearls and Other Issues", "content": "Huntington's disease presents with a slow onset with a progressive course, is typically associated with family history, and ultimately leads to dementia and death. Other rarer genetic causes can be considered if clinical or familiar history is suggestive.", "contents": "Sydenham Chorea -- Pearls and Other Issues. Huntington's disease presents with a slow onset with a progressive course, is typically associated with family history, and ultimately leads to dementia and death. Other rarer genetic causes can be considered if clinical or familiar history is suggestive."}
{"id": "article-29792_23", "title": "Sydenham Chorea -- Enhancing Healthcare Team Outcomes", "content": "The diagnosis and management of Sydenham chorea are\u00a0challenging. Sydenham chorea is not a benign disorder and the symptoms may last for\u00a0over\u00a02 years in some patients. In addition, despite treatment, recurrences are common. In general, when Sydenham chorea is diagnosed, the patient should be referred to a cardiologist to rule out valvular heart disease.", "contents": "Sydenham Chorea -- Enhancing Healthcare Team Outcomes. The diagnosis and management of Sydenham chorea are\u00a0challenging. Sydenham chorea is not a benign disorder and the symptoms may last for\u00a0over\u00a02 years in some patients. In addition, despite treatment, recurrences are common. In general, when Sydenham chorea is diagnosed, the patient should be referred to a cardiologist to rule out valvular heart disease."}
{"id": "article-29792_24", "title": "Sydenham Chorea -- Enhancing Healthcare Team Outcomes", "content": "Aggressively treating group A \u03b2-hemolytic streptococcal pharyngeal infection\u00a0and reducing the likelihood of rheumatic heart disease is effective in Sydenham chorea prevention. Once Sydenham chorea is diagnosed, secondary antibiotic\u00a0prophylaxis is indicated to decrease the risk of neurologic and cardiac problems with future streptococcal infections. The WHO recommends secondary prophylaxis in those younger than 21. The prognosis of patients with Sydenham chorea is guarded. During the acute phase, the symptoms are disabling and the quality of life is poor. [17]", "contents": "Sydenham Chorea -- Enhancing Healthcare Team Outcomes. Aggressively treating group A \u03b2-hemolytic streptococcal pharyngeal infection\u00a0and reducing the likelihood of rheumatic heart disease is effective in Sydenham chorea prevention. Once Sydenham chorea is diagnosed, secondary antibiotic\u00a0prophylaxis is indicated to decrease the risk of neurologic and cardiac problems with future streptococcal infections. The WHO recommends secondary prophylaxis in those younger than 21. The prognosis of patients with Sydenham chorea is guarded. During the acute phase, the symptoms are disabling and the quality of life is poor. [17]"}
{"id": "article-29792_25", "title": "Sydenham Chorea -- Enhancing Healthcare Team Outcomes", "content": "To enhance patient-centered care, outcomes, safety, and team performance related to Sydenham chorea, a collaborative approach involving physicians, advanced practitioners, nurses, pharmacists, and other health professionals is crucial. Healthcare teams should possess specialized diagnostic and treatment skills, with physicians and advanced practitioners addressing the unique challenges of Sydenham chorea. Nurses play a vital role in monitoring symptom progression and providing supportive care, while pharmacists ensure proper medication management and address potential drug interactions. Developing a comprehensive care strategy that considers the immune-mediated nature of Sydenham chorea and involves evidence-based interventions is essential. Effective interprofessional communication is key, facilitating regular updates and shared insights among team members. Coordinated care, including seamless transitions between settings and collaboration with specialists, enhances the overall care approach. Patient-centered care is emphasized by involving patients and families in decision-making and providing educational resources. Regular assessment of outcomes, prioritizing patient safety, and fostering a collaborative team environment contribute to optimizing care for Sydenham chorea.", "contents": "Sydenham Chorea -- Enhancing Healthcare Team Outcomes. To enhance patient-centered care, outcomes, safety, and team performance related to Sydenham chorea, a collaborative approach involving physicians, advanced practitioners, nurses, pharmacists, and other health professionals is crucial. Healthcare teams should possess specialized diagnostic and treatment skills, with physicians and advanced practitioners addressing the unique challenges of Sydenham chorea. Nurses play a vital role in monitoring symptom progression and providing supportive care, while pharmacists ensure proper medication management and address potential drug interactions. Developing a comprehensive care strategy that considers the immune-mediated nature of Sydenham chorea and involves evidence-based interventions is essential. Effective interprofessional communication is key, facilitating regular updates and shared insights among team members. Coordinated care, including seamless transitions between settings and collaboration with specialists, enhances the overall care approach. Patient-centered care is emphasized by involving patients and families in decision-making and providing educational resources. Regular assessment of outcomes, prioritizing patient safety, and fostering a collaborative team environment contribute to optimizing care for Sydenham chorea."}
{"id": "article-29792_26", "title": "Sydenham Chorea -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Sydenham Chorea -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}